Results 11 to 20 of about 1,462 (110)

Case report: Self-administration of alpha-1 antitrypsin therapy: a report of two cases

open access: yesFrontiers in Pharmacology, 2023
Intravenous augmentation therapy with human alpha-1 proteinase inhibitor for the management of respiratory disease is recommended for people with alpha-1 antitrypsin deficiency (AATD) who are nonsmokers or former smokers.
Ana M. Escribano Dueñas   +3 more
doaj   +1 more source

Pindolol augmentation of antidepressant therapy [PDF]

open access: yesBritish Journal of Psychiatry, 1998
BackgroundAntidepressant therapy is not always effective and is slow to take effect. In theory, these shortfalls may be caused by induction of neuronal negative feedback via pre-synaptic 5-HTIA receptors. Pindolol, an antagonist at somatodentritic pre-synaptic 5-HTIA receptors has been investigated as a potential accelerator and augmenter of ...
R, McAskill, S, Mir, D, Taylor
openaire   +3 more sources

Diagnosis and augmentation therapy for alpha-1 antitrypsin deficiency: current knowledge and future potential

open access: yesDrugs in Context, 2023
The underdiagnosis of alpha-1 antitrypsin (AAT) deficiency (AATD) has been recognized for many years, yet little progress has been made in treatment of the disease.
Paulo Henrique Feitosa
doaj   +1 more source

Long Non-Coding RNA Expression in Alpha-1 Antitrypsin Deficient Monocytes Pre- and Post-AAT Augmentation Therapy

open access: yesNon-Coding RNA, 2023
Long non-coding RNAs (lncRNAs) regulate gene expression. Their expression in alpha-1 antitrypsin (AAT) deficiency has not been investigated. Treatment of AAT deficiency involves infusion of plasma-purified AAT and this augmentation therapy has previously
Stephen G. J. Smith, Catherine M. Greene
doaj   +1 more source

Augmentation therapy with human alpha-1-proteinase inhibitor reduces exacerbations in patient with bronchiectasis and alpha-1-antitrypsin deficiency

open access: yesRespiratory Medicine Case Reports, 2022
Alpha-1-antitrypsin deficiency (AATD) is a rare cause of noncystic fibrosis (CF) bronchiectasis. The benefits of augmentation therapy in patients with chronic obstructive pulmonary disease (COPD) and pulmonary emphysema are well established.
Emanuel Buck   +6 more
doaj   +1 more source

Moving beyond first-line treatment options for OCD [PDF]

open access: yesMental Health Clinician, 2022
OCD is characterized by obsessions and compulsions that cause distress, are time-consuming, and interfere with a patient's social, occupational, or other areas of functioning.
Chris Paxos, PharmD, BCGP, BCPS, BCPP
doaj   +1 more source

Preparatory Knee Flexion-Extension Movements Enhance Rapid Sidestepping Performance in Collegiate Basketball Players

open access: yesFrontiers in Sports and Active Living, 2021
Lower-limb weight-bearing load distribution in stationary standing influences the timing of rapid first step initiation of importance for functional movement activities and agility performance in sports.
Masahiro Fujimoto   +4 more
doaj   +1 more source

Can facet joint block be a complementary or alternative therapeutic option for patients with osteoporotic vertebral fractures: a meta-analysis

open access: yesJournal of Orthopaedic Surgery and Research, 2022
Background Recently facet joint block has been increasingly used to relief the residual pain after vertebral augmentation, but whether it can be a complementary or alternative to vertebral augmentation remain largely unknown. Thus, we conducted this meta-
Zhi Chen   +4 more
doaj   +1 more source

Long-term experience in the treatment of α1-antitrypsin deficiency: 25 years of augmentation therapy [PDF]

open access: yesEuropean Respiratory Review, 2015
Although it is often under-recognised, α1-antitrypsin deficiency (AATD) represents one of the most common genetic respiratory disorders worldwide. Since the publication of studies in the late 1980s, which demonstrated that plasma-derived augmentation ...
Helmut Teschler
doaj   +1 more source

Exploring the causes of augmentation in restless legs syndrome

open access: yesFrontiers in Neurology, 2023
Long-term drug treatment for Restless Legs Syndrome (RLS) patients can frequently result in augmentation, which is the deterioration of symptoms with an increased drug dose.
Pengyu Zeng   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy